These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 11115455)

  • 1. Quantification of cytomegalovirus DNA in BAL fluid: a longitudinal study in lung transplant recipients.
    Riise GC; Andersson R; Bergström T; Lundmark A; Nilsson FN; Olofsson S
    Chest; 2000 Dec; 118(6):1653-60. PubMed ID: 11115455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients.
    Costa C; Astegiano S; Terlizzi ME; Sidoti F; Curtoni A; Solidoro P; Baldi S; Bergallo M; Cavallo R
    Transplant Proc; 2011 May; 43(4):1159-61. PubMed ID: 21620077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association of cytomegalovirus DNA concentration in epithelial lining fluid and symptomatic cytomegalovirus infection in lung transplant recipients.
    Zedtwitz-Liebenstein K; Jaksch P; Bauer C; Popow T; Klepetko W; Hofmann H; Puchhammer-Stöckl E
    Transplantation; 2004 Jun; 77(12):1897-9. PubMed ID: 15223910
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Detection of CMV pneumonitis after lung transplantation using PCR of DNA from bronchoalveolar lavage cells.
    Bewig B; Haacke TC; Tiroke A; Bastian A; Böttcher H; Hirt SW; Rautenberg P; Haverich A
    Respiration; 2000; 67(2):166-72. PubMed ID: 10773788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of quantitative cytomegalovirus detection in bronchoalveolar lavage fluid in lung transplant recipients.
    Schlischewsky E; Fuehner T; Warnecke G; Welte T; Haverich A; Ganzenmueller T; Heim A; Gottlieb J
    Transpl Infect Dis; 2013 Feb; 15(1):60-9. PubMed ID: 23025532
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytomegalovirus disease and infection in lung transplant recipients in the setting of planned indefinite valganciclovir prophylaxis.
    Wiita AP; Roubinian N; Khan Y; Chin-Hong PV; Singer JP; Golden JA; Miller S
    Transpl Infect Dis; 2012 Jun; 14(3):248-58. PubMed ID: 22385394
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relationship between cytomegalovirus DNA load in epithelial lining fluid and plasma of lung transplant recipients and analysis of coinfection with Epstein-Barr virus and human herpesvirus 6 in the lung compartment.
    Bauer CC; Jaksch P; Aberle SW; Haber H; Lang G; Klepetko W; Hofmann H; Puchhammer-Stöckl E
    J Clin Microbiol; 2007 Feb; 45(2):324-8. PubMed ID: 17151208
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical utility of cytomegalovirus viral load in bronchoalveolar lavage in lung transplant recipients.
    Chemaly RF; Yen-Lieberman B; Chapman J; Reilly A; Bekele BN; Gordon SM; Procop GW; Shrestha N; Isada CM; Decamp M; Avery RK
    Am J Transplant; 2005 Mar; 5(3):544-8. PubMed ID: 15707409
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cytomegalovirus Viral Load in Bronchoalveolar Lavage to Diagnose Lung Transplant Associated CMV Pneumonia.
    Lodding IP; Schultz HH; Jensen JU; Kirkby N; Perch M; Andersen C; Lundgren JD; Iversen M
    Transplantation; 2018 Feb; 102(2):326-332. PubMed ID: 28846557
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation between viral loads of cytomegalovirus in blood and bronchoalveolar lavage specimens from lung transplant recipients determined by histology and immunohistochemistry.
    Chemaly RF; Yen-Lieberman B; Castilla EA; Reilly A; Arrigain S; Farver C; Avery RK; Gordon SM; Procop GW
    J Clin Microbiol; 2004 May; 42(5):2168-72. PubMed ID: 15131185
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pulmonary cytomegalovirus (CMV) DNA shedding in allogeneic hematopoietic stem cell transplant recipients: Implications for the diagnosis of CMV pneumonia.
    Piñana JL; Giménez E; Gómez MD; Pérez A; González EM; Vinuesa V; Hernández-Boluda JC; Montoro J; Salavert M; Tormo M; Amat P; Moles P; Carretero C; Balaguer-Roselló A; Sanz J; Sanz G; Solano C; Navarro D
    J Infect; 2019 May; 78(5):393-401. PubMed ID: 30797790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human cytomegalovirus load in plasma and bronchoalveolar lavage fluid: a longitudinal study of lung transplant recipients.
    Westall GP; Michaelides A; Williams TJ; Snell GI; Kotsimbos TC
    J Infect Dis; 2004 Sep; 190(6):1076-83. PubMed ID: 15319856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of human cytomegalovirus in bronchoalveolar lavage fluid of lung transplant recipients reflects local virus replication and not contamination from the throat.
    Kerschner H; Jaksch P; Zweytick B; Puchhammer-Stöckl E
    J Clin Microbiol; 2010 Nov; 48(11):4273-4. PubMed ID: 20810778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rapid detection of cytomegalovirus in bronchoalveolar lavage fluid and serum samples by polymerase chain reaction: correlation of virus isolation and clinical outcome for patients with human immunodeficiency virus infection.
    Hansen KK; Vestbo J; Benfield T; Lundgren JD; Mathiesen LR
    Clin Infect Dis; 1997 May; 24(5):878-83. PubMed ID: 9142786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Semiquantitative measurement of cytomegalovirus DNA in lung and heart-lung transplant patients by in vitro DNA amplification.
    Cagle PT; Buffone G; Holland VA; Samo T; Demmler GJ; Noon GP; Lawrence EC
    Chest; 1992 Jan; 101(1):93-6. PubMed ID: 1309500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cytological monitoring of peripheral blood, bronchoalveolar lavage fluid, and transbronchial biopsy specimens during acute rejection and cytomegalovirus infection in lung and heart--lung allograft recipients.
    Tikkanen J; Lemström K; Halme M; Pakkala S; Taskinen E; Koskinen P
    Clin Transplant; 2001 Apr; 15(2):77-88. PubMed ID: 11264632
    [TBL] [Abstract][Full Text] [Related]  

  • 17. When polymerase chain reaction does not help: cytomegalovirus pneumonitis associated with very low or undetectable viral load in both blood and bronchoalveolar lavage samples after lung transplantation.
    Coussement J; Steensels D; Nollevaux MC; Bogaerts P; Dumonceaux M; Delaere B; Froidure A
    Transpl Infect Dis; 2016 Apr; 18(2):284-7. PubMed ID: 26910136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of Roche COBAS
    Hildenbrand C; Wedekind L; Li G; vonRentzell JE; Shah K; Rooney P; Harrington AT; Zhao RY
    J Med Virol; 2018 Oct; 90(10):1611-1619. PubMed ID: 29797374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs and outcomes of prolonged cytomegalovirus prophylaxis to cover the enhanced immunosuppression phase following lung transplantation.
    Gerbase MW; Dubois D; Rothmeier C; Spiliopoulos A; Wunderli W; Nicod LP
    Chest; 1999 Nov; 116(5):1265-72. PubMed ID: 10559085
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cytomegalovirus infection in immunocompetent wheezy infants: the diagnostic value of CMV PCR in bronchoalveolar lavage fluid.
    Cinel G; Pekcan S; Ozçelik U; Alp A; Yalçın E; Doğru Ersöz D; Kiper N
    J Clin Pharm Ther; 2014 Aug; 39(4):399-403. PubMed ID: 25040449
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.